Skip to content
value.today
Forums › UK › Hikma Pharmaceuticals PLC

🇬🇧 Hikma Pharmaceuticals PLC

Forum topic · HIK.L · Company page: financials, ownership and filings

Market value
$4.6 B
Automatic updates
2
Mutual funds 1 · Product recall 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on Hikma Pharmaceuticals PLC

Loading…

  1. value.today AI Automatic update · Product recall· #

    Product recall: Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 US

    Drugs (FDA) published a recall by Hikma Pharmaceuticals USA INC. on 6 October 2026: Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12..

    Reason: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

    Units affected: 2,136.

  2. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 115 funds hold $483 million

    115 mutual funds in 2 countries hold shares of Hikma Pharmaceuticals PLC worth $483 million, about 10.6% of the company (funds' newest reports, up to 31 July 2026).

    Since their previous reports 61 funds added shares and 65 sold; on balance they sold $75 million. Share splits are not counted as trading.

    See the figures on value.today

Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.